Cargando…

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19

Detalles Bibliográficos
Autores principales: Gozzetti, Alessandro, Capochiani, Enrico, Bocchia, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467142/
https://www.ncbi.nlm.nih.gov/pubmed/32879427
http://dx.doi.org/10.1038/s41375-020-01038-8
_version_ 1783577955785506816
author Gozzetti, Alessandro
Capochiani, Enrico
Bocchia, Monica
author_facet Gozzetti, Alessandro
Capochiani, Enrico
Bocchia, Monica
author_sort Gozzetti, Alessandro
collection PubMed
description
format Online
Article
Text
id pubmed-7467142
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-74671422020-09-03 The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 Gozzetti, Alessandro Capochiani, Enrico Bocchia, Monica Leukemia Correspondence Nature Publishing Group UK 2020-09-02 2020 /pmc/articles/PMC7467142/ /pubmed/32879427 http://dx.doi.org/10.1038/s41375-020-01038-8 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Gozzetti, Alessandro
Capochiani, Enrico
Bocchia, Monica
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
title The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
title_full The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
title_fullStr The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
title_full_unstemmed The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
title_short The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19
title_sort janus kinase 1/2 inhibitor ruxolitinib in covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467142/
https://www.ncbi.nlm.nih.gov/pubmed/32879427
http://dx.doi.org/10.1038/s41375-020-01038-8
work_keys_str_mv AT gozzettialessandro thejanuskinase12inhibitorruxolitinibincovid19
AT capochianienrico thejanuskinase12inhibitorruxolitinibincovid19
AT bocchiamonica thejanuskinase12inhibitorruxolitinibincovid19
AT gozzettialessandro januskinase12inhibitorruxolitinibincovid19
AT capochianienrico januskinase12inhibitorruxolitinibincovid19
AT bocchiamonica januskinase12inhibitorruxolitinibincovid19